Intensity Therapeutics Inc

XNAS:INTS 4:00:00 PM EDT

0.44

+0.02 (+3.61%)

5:59:36 PM EDT: $0.42 -0.02 (-4.44%)

Intensity Therapeutics Inc Stock, XNAS:INTS

1 Enterprise Drive, Suite 430, Shelton, Connecticut 06484-4779

United States of America

Phone: +1.203.221.7381

Number of Employees: 16

http://www.intensitytherapeutics.com

Description

Intensity Therapeutics, Inc. operates as biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine. The company was founded by Lewis H. Bender in 2012 and is headquartered in Shelton, CT.